Jubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2025. - Grant of Stock Options / RSUs
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova informed the stock exchange about the outcome of its board meeting held on October 31, 2025. The board approved the grant of Stock Options and/or Restricted Stock Units (RSUs) to eligible employees under the company's stock-based incentive scheme. This is a routine employee compensation action, with the specific number of options, exercise price, and names of recipients to be disclosed separately. The grant is aimed at rewarding and retaining key talent at the company.
This may lead to minor dilution for existing shareholders once the options/RSUs are exercised in the future, but it is a normal employee incentive practice and not typically a material event for the stock price.